Skip to main content
. 2018 Mar 14;81(5):873–883. doi: 10.1007/s00280-018-3558-z

Table 2.

PK parameters for steady-state AZD5363 in Parts A and B (PK analysis set)

Parameter N Part A
Tablet Capsule Ratio tablet:capsule
Gmean (CV%) Gmean (CV%) GLSM ratio 90% CI
AUCτ, h ng/mL 11 8536 (47.7) 9445 (44.6) 0.90 0.77, 1.06
Cmax, ng/mL 11 1779 (46.2) 1745 (40.2) 1.02 0.86, 1.20
Cmin, ng/mL 11 192.6 (55.6) 271.5 (57.7) NC NC
tmax, ha 11 1.0 (0.6–2) 2.0 (1–4)
Parameter N Part B
Fasted Fed Ratio fed:fasted
Gmean (CV%) Gmean (CV%) GLSM ratio 90% CI
AUCτ, h ng/mL 9 9116 (16.8) 8136 (33.9) 0.89 0.76, 1.05
Cmax, ng/mL 9 1842 (31.1) 1239 (23.3) 0.67 0.55, 0.82
Cmin, ng/mL 9 218.5 (30.3) 262.3 (58.6) NC NC
tmax, ha 9 0.6 (0.5–4) 2.0 (2–4.3)

CV coefficient of variation, GLSM geometric least-squares mean, Gmean geometric mean, NC not calculated

aMedian (range)